Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MTBVAC in adolescents and adults living with and without HIV in South Africa
NCT05947890Phase 2Recruiting
- Sponsor
- HIV Vaccine Trials Network
- Start
- Jan 2024
- Primary completion
- Nov 2027
- Modality
- Live Biotherapeutic Products, Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 2 trial of mtbvac in Tuberculosis (TB), sponsored by HIV Vaccine Trials Network. Started Jan 2024; status: recruiting.
02
Drugs
mtbvac
03
Conditions
Tuberculosis (TB)
Beyond the preview
Go deeper on NCT05947890.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05947890.